- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Stage IB-IIA-IIIA Non-Small Cell Lung Cancer; EGFRm ; Ex19Del; L858R; AZD9291; Phase III, adjuvant c
Total 492910 results
-
Merck Sharp & Dohme LLCCompletedNon-small Cell Lung CancerUnited States, Australia, France, Germany, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, United Kingdom
-
AstraZenecaCompletedNon-small Cell Lung CancerItaly, Poland, France, Spain, United States, Russian Federation
-
Bristol-Myers SquibbActive, not recruitingCarcinoma, Non-Small-Cell LungRussian Federation, Belgium, United States, Australia, Argentina, Brazil, Canada, China, Czechia, France, Germany, Ireland, Italy, Japan, Mexico, Netherlands, Poland, Puerto Rico, Romania, Spain, Taiwan, United Kingdom
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced Non Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States, Australia, France, Italy, Korea, Republic of, Poland, Russian Federation, Spain, United Kingdom, China, Romania, Netherlands, Hong Kong, Austria, Belgium, Czechia, Hungary, Portugal, Greece, Germany, Ireland, Switze... and more
-
National Cancer Institute (NCI)CompletedRecurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Extensive Stage Small Cell Lung Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage II Pancreatic Cancer | Stage IVA Pancreatic Cancer | Stage IVB Pancreatic Cancer | Stage I Pancreatic Cancer | Stage II Non-small Cell Lung Cancer | Stage III Colon Cancer and other conditionsUnited States
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerItaly, United States, Argentina, Belgium, Germany, Israel, Poland, Spain, Turkey, Australia, Chile, France
-
ImmunityBio, Inc.Active, not recruitingNon Small Cell Lung CancerUnited States
-
National Cancer Centre, SingaporePfizerActive, not recruitingNSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung CancerKorea, Republic of, Hong Kong, Thailand, Singapore, Malaysia
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lung CancerUnited States, Germany, Canada, France, Spain, Japan, Taiwan, Italy, Argentina, Austria, Poland, Russian Federation, United Kingdom, Korea, Republic of, Hong Kong, Thailand, Lebanon, Bulgaria, Greece, Israel, Slovenia, Switzerland, ... and more
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingNon Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Lung Cancer, Nonsmall CellUnited States
-
Julia K. Rotow, MDInivataActive, not recruitingMetastatic Non-Small Cell Lung Cancer | NSCLC Stage IVUnited States
-
Edward PatzActive, not recruitingNon-small Cell Lung CancerUnited States
-
Fundación GECPActive, not recruitingNon-Small Cell Lung Cancer | Adjuvant ChemotherapySpain
-
Fundación GECPActive, not recruiting
-
MIPO ClinicCompletedNonsmall-cell Lung CancerKazakhstan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingNon-Small Cell Lung CancerUnited States, Italy, Poland, Spain, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czechia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Japan, Korea, Republic of, Lebanon, Mexico, Netherlands and more
-
Novartis PharmaceuticalsActive, not recruitingNon-small Cell Lung CancerUnited States
-
Joel NealNektar TherapeuticsCompletedTumors Metastatic to Brain | Stage IV Non-small Cell Lung Cancer (NSCLC) | Recurrent Non-small Cell Lung Cancer (NSCLC) | Extensive-stage Small Cell Lung Cancer (SCLC) | Recurrent Small Cell Lung Cancer (SCLC) | Metastatic Breast Cancer (mBC)United States
-
Greg Durm, MDAstraZeneca; Indiana University School of MedicineTerminatedNon Small Cell Lung Cancer | Stage III Non-small-cell Lung CancerUnited States
-
Canadian Cancer Trials GroupNational Health and Medical Research Council, Australia; Dutch Society of Physicians... and other collaboratorsActive, not recruitingNon-Small Cell Lung CancerCanada, United States, France, Spain, Taiwan, China, Australia, Italy, Japan, Singapore, Korea, Republic of, New Zealand, Netherlands, Romania, Bulgaria, Brazil, Hungary, Poland, Ukraine
-
Mario Negri Institute for Pharmacological ResearchAstraZeneca; Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoActive, not recruitingNon-small Cell Lung Cancer Stage IIIItaly, Spain, France
-
University of Texas Southwestern Medical CenterAstraZenecaActive, not recruitingNon Small Cell Lung Cancer | Lung Cancer Stage IIIUnited States
-
Shanghai Henlius BiotechActive, not recruitingSquamous Non Small Cell Lung CancerChina, Turkey, United States, Georgia, Poland, Russian Federation, Ukraine
-
Merck Sharp & Dohme LLCActive, not recruitingNon-small Cell Lung CancerUnited States, Argentina, Australia, Belgium, Brazil, Canada, China, Estonia, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Malaysia, Poland, Romania, Russian Federation, South Africa, Spain, Taiwan, U... and more
-
Jeffrey ClarkeCompletedNon-small Cell Lung CancerUnited States
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung CancerCanada, Netherlands, Spain, France, Japan, Russian Federation, Germany, Belgium, Greece, Turkey, Taiwan, United States
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingStage II-III Non-small Cell Lung CancerChina
-
Assistance Publique Hopitaux De MarseilleTerminated
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
University of Texas Southwestern Medical CenterCompletedStage IV Non-Small Cell Lung CancerUnited States
-
University of Wisconsin, MadisonAstraZenecaTerminatedNon-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage IVUnited States
-
Proton Collaborative GroupActive, not recruitingLung NeoplasmsUnited States
-
National Cancer Institute, NaplesUniversity of Campania "Luigi Vanvitelli"Active, not recruiting
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedStage IV or Recurrent Non-Small Cell Lung CancerUnited States, Finland, Argentina, France, Italy, Brazil, Greece, Japan, Mexico, Romania, Spain, Sweden, United Kingdom, Australia, Austria, Belgium, Canada, Czechia, Germany, Hungary, Korea, Republic of, Netherlands, Poland, Switzerland and more
-
H. Lee Moffitt Cancer Center and Research InstituteArray BioPharmaCompletedNon-Small Cell Lung Cancer | Lung CancerUnited States
-
ETOP IBCSG Partners FoundationHoffmann-La Roche; AstraZenecaActive, not recruitingNon Small Cell Lung Cancer MetastaticIreland, Singapore, Spain, Switzerland, Korea, Republic of, Netherlands
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Active, not recruitingNon-small Cell Lung CancerChina
-
ImmunityBio, Inc.Withdrawn
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Cancer Institute and Hospital, Chinese Academy...Jiangsu Hansoh Pharmaceutical Co., Ltd.; GeneCast Biotechnology Co., Ltd.Enrolling by invitation
-
Jair Bar, M.D., Ph.D.Merck Sharp & Dohme LLCCompletedNon Small Cell Lung Carcinoma | Stage II | Stage IIsrael
-
Massachusetts General HospitalCompletedSmall Cell Lung Carcinoma | Non-small Cell Lung CarcinomaUnited States
-
Betta Pharmaceuticals Co., Ltd.Active, not recruitingNon-small Cell Lung CancerChina
-
Hoffmann-La RocheWithdrawn
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Gustave Roussy, Cancer Campus, Grand ParisEuropean Organisation for Research and Treatment of Cancer - EORTC; Intergroupe... and other collaboratorsUnknownNon-small Cell Lung CancerFrance
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkUnknown
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Guangdong Association of Clinical TrialsPeking University First Hospital; Zhejiang Cancer Hospital; Peking University... and other collaboratorsUnknownNon-small Cell Lung CancerChina
-
Acrotech Biopharma Inc.OnxeoCompletedStage IV Non-small Cell Lung CancerUnited States